Growth hormone release
Ipamorelin
The selective growth-hormone secretagogue
Format
Add a refill for your pen
Ipamorelin 10 mg · +AED 685 each
Quantity — buy more, save more
Other quantity
Any mix counts: items from other products add up too.
Frequently paired with
Tap Add — each one counts toward your bundle saving.
CJC-1295 (No DAC) 10 mg
AED 780
Sermorelin 5 mg
AED 780
Also in a bundle: GH research duo · Sleep & recovery
Add another item from the catalogue
Pens are added as the reusable pen; change the format on the product page if you prefer.
A selective secretagogue that triggers pulsatile growth-hormone release without a matching rise in cortisol or prolactin. The most studied of its group in lean-mass, recovery and sleep research.
Research use only. Supplied for laboratory and analytical research. Not a medicine or supplement, and not for human or animal use. We don't give dosing or clinical advice. Read the terms
- Presentation
- Lyophilised powder, reconstituted — 3 mL pen
Manufactured under controlled research-grade conditions. For documentation or questions about this compound, contact us on WhatsApp.
Published research
- Human trial
In healthy male volunteers, intravenous ipamorelin produced a single episode of growth hormone release at every level tested and had a short terminal half-life of about two hours.
Gobburu JV, et al. Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers. Pharmaceutical Research. 1999. PMID 10496658
- Animal study
In adult female rats, ipamorelin dose-dependently increased longitudinal bone growth rate and body-weight gain without changing total IGF-I or bone turnover markers.
Johansen PB, et al. Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in rats. Growth Hormone & IGF Research. 1999. PMID 10373343
- Animal study
In adult female rats, 12 weeks of continuous ipamorelin increased bone mineral content through larger bone size rather than denser bone (volumetric density unchanged), alongside body-weight gain; GHRP-6 and GH were tested in separate groups.
Svensson J, et al. The GH secretagogues ipamorelin and GH-releasing peptide-6 increase bone mineral content in adult female rats. The Journal of Endocrinology. 2000. PMID 10828840
Short summaries of published studies, with links to the original papers. Results in animals or cells may not apply to people. This is not medical advice and not a guide to use.
All research on Ipamorelin